Warrington, PA, United States of America

Michael Rausch


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Inventive Journey of Michael Rausch

Introduction

Michael Rausch, a distinguished inventor based in Warrington, PA, has made significant contributions to the field of medical technology. His innovative approach has led to the development of a unique method for determining fibrinogen levels in blood plasma, addressing critical needs in patient care and diagnostics.

Latest Patents

Among his achievements, Michael holds a notable patent titled "Method for determining the fibrinogen level of a blood sample." This ground-breaking method employs an optical density-based prothrombin time test. It introduces a novel parameter, DELTA, which effectively mitigates the statistical inaccuracies observed in prior art test methods. By calculating DELTA points from blood samples with known fibrinogen levels that span low, normal, and high ranges, Michael's method constructs a piecewise function to accurately determine a patient’s fibrinogen level, employing four equations stored in non-volatile memory.

Career Highlights

Michael Rausch is currently associated with Bio/data Corporation, where he works alongside talented colleagues such as Hyman Grossman. His work at the company focuses on pushing the boundaries of medical diagnostics, utilizing innovative technologies that enhance the accuracy of blood testing. His dedication and expertise have positioned him as a key contributor to advancements in the healthcare sector.

Collaborations

Throughout his career, Michael has collaborated with various professionals in the field, including researchers and engineers, to refine his inventions. These partnerships have been instrumental in the successful development and application of his patented method, underscoring the collaborative nature of innovation in medical technology.

Conclusion

In conclusion, Michael Rausch exemplifies the spirit of innovation, combining technical skill with a commitment to improving healthcare outcomes. His patent, focused on accurately determining fibrinogen levels, is a testament to his ingenuity and dedication to advancing medical diagnostics. As he continues to work at Bio/data Corporation, the impact of his inventions will likely be felt for years to come, contributing substantially to the field of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…